1. Home
  2. PHGE vs GP Comparison

PHGE vs GP Comparison

Compare PHGE & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • GP
  • Stock Information
  • Founded
  • PHGE 2015
  • GP 2010
  • Country
  • PHGE Israel
  • GP Canada
  • Employees
  • PHGE N/A
  • GP N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • GP Construction/Ag Equipment/Trucks
  • Sector
  • PHGE Health Care
  • GP Consumer Discretionary
  • Exchange
  • PHGE Nasdaq
  • GP Nasdaq
  • Market Cap
  • PHGE 12.6M
  • GP 10.5M
  • IPO Year
  • PHGE N/A
  • GP 2020
  • Fundamental
  • Price
  • PHGE $0.48
  • GP $3.40
  • Analyst Decision
  • PHGE Strong Buy
  • GP Strong Buy
  • Analyst Count
  • PHGE 1
  • GP 1
  • Target Price
  • PHGE $15.00
  • GP $30.00
  • AVG Volume (30 Days)
  • PHGE 389.8K
  • GP 258.8K
  • Earning Date
  • PHGE 11-13-2025
  • GP 11-13-2025
  • Dividend Yield
  • PHGE N/A
  • GP N/A
  • EPS Growth
  • PHGE N/A
  • GP N/A
  • EPS
  • PHGE N/A
  • GP N/A
  • Revenue
  • PHGE N/A
  • GP $18,399,688.00
  • Revenue This Year
  • PHGE N/A
  • GP $81.12
  • Revenue Next Year
  • PHGE N/A
  • GP $91.69
  • P/E Ratio
  • PHGE N/A
  • GP N/A
  • Revenue Growth
  • PHGE N/A
  • GP N/A
  • 52 Week Low
  • PHGE $0.34
  • GP $2.28
  • 52 Week High
  • PHGE $1.16
  • GP $19.00
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 50.36
  • GP 49.96
  • Support Level
  • PHGE N/A
  • GP $3.09
  • Resistance Level
  • PHGE $0.51
  • GP $3.66
  • Average True Range (ATR)
  • PHGE 0.03
  • GP 0.42
  • MACD
  • PHGE -0.03
  • GP 0.06
  • Stochastic Oscillator
  • PHGE 85.12
  • GP 69.75

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

About GP GreenPower Motor Company Inc.

GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.

Share on Social Networks: